The Arf GTPase-activating protein ArfGAP1 and its brain-specific isoform ArfGAP1
Introduction
ADP-ribosylation factor GTPase-activating protein 1 (ArfGAP1) is a well-known regulator of vesicle cycling through the Coat Protein Complex I (COPI) system that mediates retrograde Golgi to ER transport [1] . The ArfGAP1 protein is ubiquitously expressed in many tissues with the highest level found in liver and brain. Our previous studies demonstrated that the major ArfGAP1 isoform in the rat brain (ArfGAP1 B ) contain an in-frame insertion of 10 amino acids after residue 239, and a deletion of 22 amino acids after ArfGAP1 residue 259. These insertion/deletion regions might function as alternative Golgi localization determinants [2] or may have yet undetermined regulatory functions in the brain.
Protein trafficking in neurons plays essential roles in the establishment and maintenance of cell morphology and synaptic function. Recent findings indicated that ArfGAP1 plays a role in trafficking in neurons that may differ from its function as a COPI regulator. Thus, it was found that ArfGAP1 can regulate trafficking and targeting of the GABA transporter-1 in the axonal terminals [3] . More recently, ArfGAP1
B was found to function as a regulator of neurotransmission via the formation of tripartite AP-1/σ1A-ArfGAP1-Rabex-5 complexes [4] . Taken together, the aforementioned research suggests that ArfGAP1 B might be an essential regulator of a variety of brain functions including nerve cell secretion, signaling, neurotransmission and neurodegeneration. Here, we carried out a morphological study aimed at revealing how ArfGAP1 is distributed among different regions of the mouse brain.
Materials and methods

Animals and sample preparation
Experiments involved mouse brain tissues preparations were conducted using brains extracted from corps of eight-week-old naïve adult males CD1 mice, which had not received any special treatment or stress, and kindly donated for our investigation by Prof. Cohen, Technion, Biology Department, Haifa, Israel. Prior performing our experiments, we had consulted with the Institutional Animal Care and Use Committee (IACUC) of the Technion, Haifa, Israel and confirmed that a special approval for the usage of mice corpses was not required. All ethic procedures involving housing, handling and euthanizing animals were carried out in the Laboratory of Prof. Cohen in accordance with their IACUC approved protocol. After brains were removed from the skull, they were washed with ice-cold phosphate-buffered saline (PBS) followed by 4% paraformaldehyde fixation and overnight incubation in 30% sucrose in PBS. Brains were stored in OCT (Tissue-Tek, Netherlands) at -20˚C and sectioned on a CM1860cryostat (Leica biosystems, Germany) at 30 μm followed by immunohistochemical processing. For protein analysis, several brain regions were immediately isolated from mice brains without fixation and carefully cleaned in ice-cold PBS followed by protein extraction.
Immunohistochemistry
Brain tissue sections were washed in ice-cold PBS, incubated in 1% NaBH4 for 15 min to decrease autofluorescence, and permeabilized in TBST (PBS with 0.3% v/v Triton X-100) for 30 min followed by incubation for 2 hrs in blocking buffer containing 5% w/v bovine serum albumin (BSA, Sigma-Aldrich), 5% v/v goat serum (Sigma-Aldrich) and 5% w/v normal donkey serum (Jackson ImmunoResearch) in PBST. Sections were immunostained with rabbit anti-ArfGAP1 (1:400, ab183746, AbCam, UK), rabbit ArfGAP1 antibodies against the insertion peptide that is present in the brain/heart isoforms previously generated by us [2] (1:400), mouse anti-ZnT3 (1:100, Synaptic Systems, France), mouse anti-GFAP (1:500, Millipore, USA) overnight at 4˚C, washed with PBS and incubated for 1 hr with appropriate secondary antibodies (1:400, Alexa-488 conjugated anti-rabbit and CY3 conjugated anti-mouse from Jackson Immuno Research, USA). Sections were then washed in PBS, incubated with DAPI (1 mg/ml, Sigma-Aldrich) for 5 min or NeuroTrace™ 530/615 for 2 hrs (1:50, Thermofisher Sci) followed by washing in water, and mounted on glass slides. Images were acquired using a Nicon A1-R confocal microscope for whole-brain mapping of ArfGAP1 localization (coronal view, bregma -1,94 mm and sagittal view, lateral 1.68 mm) and a Zeiss LSM 700 laser scanning confocal microscope (Germany) for more detailed analysis (coronal view bregma -1.94) at 10X.
Western blot assay
Proteins were extracted from 100 μg of brain tissue after homogenization using 100 μl of 20mM Tris-HCl buffer (pH 7,5), sonicated (Misonix Sonicator, USA), centrifuged and protein concentration in the supernatant was assayed using the Nano Drop ND-1000 spectrophotometer (Thermo Fisher Scientific, USA). Aliquots of the extract containing 50 μg protein were separated by reducing SDS-PAGE (10%) and electroblotted onto nitrocellulose membranes. The blots were blocked by using 0,2% EZ-block solution (Biological Industries, USA) in PBS Tris-buffered salt with Tween-20 (PBST). The blots were incubated overnight at 4˚C with rabbit anti-ArfGAP1 antibody (1:1000, ab183746, AbCam, UK) and rabbit ArfGAP1 antibodies against the insertion peptide that is present in the brain/heart isoforms previously generated by us [2] (1:3000), then incubated in goat-anti-rabbit secondary antibody-conjugated horseradish peroxide (1:2500, Sigma-Aldrich). Proteins were visualized by chemiluminescence using the Clarity Western ECL Substrate (Bio-Rad Laboratories, USA). To ensure even loading of the samples, the same membrane was probed with rabbit anti-GAPDH antibody (1:1000, AbCam). The analysis was performed by Image Quant LAS 4000 (GE HealthCare Life Science, USA). The intensity of the ArfGAP1 band in each sample was normalized relative to GAPDH.
Statistical analysis
Linear regression analysis was performed using Excel (Microsoft). Quantification of Western Blot data was conducted using Prism (GraphPad, USA). Data correspond to means ± SEM, n = 3.
Results and discussion
To identify the ArfGAP1 distribution among different mouse brain regions, we performed an immunohistochemical analysis of the mouse brain using a commercial antibody recognizing all ArfGAP1 variants (ab183746, AbCam). Examination of the mouse brain showed high abundance of ArfGAP1 in the dentate gyrus (DG) and moderate level in the isocortex (IsoCtx) compared to other regions (Fig 1A and 1B) . The ArfGAP1 levels looked similar in both hemispheres. However, ArfGAP1 was not detected in most of the areas were the fibers tracts are spanning. Within the DG, ArfGAP1 displayed especially elevated level in the polymorph layer (hilus) and was absent in the granule cell bodies (Fig 2) . Interestingly, the ArfGAP1 signal follows the pathway of the DG granule cell axons so-called mossy fibers. The mossy fibers extend from the DG to CA3c and partially CA3b areas through suprapyramidal bundle in stratum lucidum together with intra-and infrapyramidal projection located mainly in stratum oriens ( Fig 2B) . We identified these projections in both coronal and sagittal brain tissue sections ( Figs  1 and 2 ).
In the IsoCtx, we found diverse levels of ArfGAP1 immunoreactivity. The most intense staining among all areas was observed in the sagittal plane such as the visual and posterior parietal association areas (PTLp) that have higher abundance compare to the somatosensory (SS) and somatomotor (MO) areas (Fig 1B) . In contrast, the other areas of the IsoCtx have low level of abundance. In addition, we detected separation of ArfGAP1 staining in the cortical layers. Thus, layers 1, 2, 3 and 5, have higher signal than layers 4 and 6a, while the layer 6b has an absent or very low immunoreactivity of ArfGAP1 as seen in both the coronal and sagittal planes (Fig 1A and 1B) and using Nissl staining (Fig 1C) .
Functionally, layers of the IsoCtx can be divided into three parts: the supragranular layers 1-3, the internal granular layer 4 and the infragranular layers 5 and 6 [5] . Layer 1 has very few neurons and cells and are mainly composed of dendrites and axons that extend from lower levels of the IsoCtx, while layer 2 contains granular cells and small pyramidal cells. Glanule cells and transverse fibers are most prominent in layer 4. In contrast, layers 3 and 5 consist mostly of pyramidal cells. Moreover, layer 5 contains giant pyramidal cells (Betz cells) which are the largest excitatory projection neurons in the brain that can project to the spinal cord and form synapses to target muscles that control movement. Layer 6 contains less common cell types, including horizontal cells, fusiform cells and the cells of Martinotti [5] . There are many staining techniques to analyze neuronal morphology and cytoarchitecture of the IsoCtx and the whole brain including conventional techniques such as Nissl, Golgi and Weigert stainings [6, 7] . However, there are difficulties in the identification of some layers using conventional techniques. Recent experimental approaches including in situ gene expression analysis allow well-defined morphological identification of the specific cortex layers (reviewed by Molyneaux et al, 2007 [8] ). Using anti-ArfGAP1 antibodies we were also able to obtain a clear visualization of the structural layers of the IsoCtx (Figs 1 and 2) . Taken together, our data suggest that the ArfGAP1 antibody can be used for visualization of the hilus of the DG including its projections to CA3 region and cortical layers in immunohistochemical studies.
We attempted to determine the distribution of the brain-specific ArfGAP1 isoform using a previously-developed antibodies directed against the ArfGAP1 B insertion peptide [2] . However, these antibodies were found inefficient in immunohistochemical staining and produced a high background. As an alternative, we performed Western Blot analysis on isolated brain regions using the antibodies recognizing all forms of ArfGAP1 or the B isoform only [2, 4] ( Fig 3A) . Both antibodies equally detected the highest level of proteins in the DG, moderate level of proteins in the IsoCtx and the lowest levels in the cerebellum (Cer), thalamus (TH) and olfactory bulbs (OB) which were approximately twice less than in the DG. These results are in agreement with the immunohistochemistry observations described above. Linear regression analysis of the data (Fig 3B) revealed the correlation between band intensities detected by antibodies that recognized total ArfGAP1 and those recognizing the brain specific isoform only (R 2 = 0.84359). As ArfGAP1 B is the major ArfGAP1 isoform in total brain [2] , our findings are in agreement with the idea that the B isoform is predominant in all brain regions examined.
Despite identified difference between ArfGAP1 levels in the Hippocampus (in the DG area) and Cer, both brain regions have anatomically similar axons-mossy fibers (Fig 4) . However, the functional properties of mossy fibers are different in each region [6] . Thus, our findings of differential expression of ArfGAP1 is probably related to functional properties of the axons. It is recognized that the hilus contains mossy cells and mossy fibers which represent the main part of this region, as well as interneurons and astrocytes [7] . The pattern of ArfGAP1 staining in this region (Fig 2) is similar to the mossy fibers projections usually seen via Timm's sulfide silver staining method [8, 9] which suggests that ArfGAP1 follows the path of mossy fibersunmyelinated axons of the granule cells. It is known that mossy fibers give rise to a distinctive set of collaterals that heavily innervate cells within the hilus and have large terminals that form en passant synapses with the mossy cells in the hilus and with the CA3 pyramidal cells [10] .
To further demonstrate the concentration of ArfGAP1 in mossy fibers of the hilus, we carried out colocalization analysis using anti-zinc transporter 3 (ZnT3) antibodies-a known marker for mossy fibers [11] and anti-glial fibrillary acidic protein (GFAP) as a marker for astrocytes [12] . We observed colocalization of the ArfGAP1 fluorescence with that of ZnT3 in dorsal and ventral regions of the hippocampus (Fig 5A and 5B) , whereas there was no colocalization between the astrocyte marker GFAP and ArfGAP1 in the hilus (Fig 5C and 5D) . Moreover, similar to ZnT3, ArfGAP1 did not highlight the mossy cells and interneuron cell bodies. The distribution of ArfGAP1-immunoreactive mossy fibers projected uniformly along the dorsoventral axis of the hilus, in agreement with the other data described above (Figs 1 and 2) . It is recognized that the pattern of ZnT-3 immunoreactivity resembles that observed with the Timm's stain since they both detect zinc-enriched mossy fibers [8, 9, 11] . However, the complexity of Timm's staining technique become a limiting factor to its applications for the studies using immunofluorescence. Our finding that ArfGAP1 is enriched in the Dentate mossy fibers adds a new perspective to use this antibody in immunofluorescence.
According to the Genome-wide atlas of gene expression in the adult mouse brain, the highest abundance of the ArfGAP1 mRNA are found in the granule cells of the DG, pyramidal cells of the hippocampus including Cornu Ammonis (CA) areas: CA1, CA2 and CA3 and partially in the cortex layer 1 [13] .
Since ArfGAP1 translocates in cultured cells between cytosol and the Golgi complex, we expected to detect the protein in the soma or dendrites. However, we did not find any specific intracellular staining. We speculate that after expression in the DG granular cells, ArfGAP1 might translocate from the soma to the axon and accumulate there.
Overall, our findings indicate that ArfGAP1 can be used as a specific marker of the Dentate mossy fibers in immunohistochemical applications. Moreover, the high level of ArfGAP1 in the hilus of the DG point to a possible regulatory role of this protein in neurotransmission. This hypothesis is further suggested by the fact that ArfGAP1 was identified as an interaction partner of GABA transporter-1 that controls the recruitment of the transporter into transport vesicles and its trafficking through the secretory pathway to the membrane in axon terminals [3] . Interestingly it was speculated that in DG the mossy fiber terminals could co-release of both GABA and glutamate [14] . However, the possible role of ArfGAP1 in the regulation of trafficking of both neurotransmitters is unknown and required further investigations. Finally, our findings suggest that focusing on processes in the mossy fibers, in particular, may yield better understanding of the function of ArfGAP1 in brain.
